THE EFFICIENCY OF DETECTION OF KRAS, EGFR AND BRAF MUTATIONS IN PRIMARY LUNG CANCER VIA PERIPHERAL BLOOD CIRCULATING TUMOUR CELLS

M.B. Freidin, D. Mair, A. Tay, D.V. Freydina, D. Chudasama, S. Popat, A.G. Nicholson, A. Rice, A. Montero-Fernandez, V. Anikin, D.G. De Castro, E. Lim

Research output: Contribution to conferenceOther contribution to conferencepeer-review

Original languageEnglish
PagesS456-S456
Publication statusPublished - Nov 2013

Keywords

  • circulating tumour cells
  • predictive testing
  • mutation detection
  • Lung cancer

Cite this